Insmed (INSM) Cash from Investing Activities (2010 - 2026)

Insmed has reported Cash from Investing Activities for 17 years, with the latest figure at $24.5 million in Q2 2026.

• On a quarterly basis, Cash from Investing Activities fell 89.24% year-over-year to $24.5 million in Q2 2026; TTM through Jun 2026 was -$82.8 million, a 85.31% increase from a year earlier, with the FY2025 full-year figure at -$64.6 million, up 88.93% from the prior year.
• Cash from Investing Activities was $24.5 million for Q2 2026 at Insmed, down from $265.5 million in the prior quarter.
• The five-year high for Cash from Investing Activities was $389.4 million in Q4 2025, with the low at -$1.0 billion in Q3 2024.
• Average Cash from Investing Activities over 5 years is -$34.2 million, with a median of $22.4 million recorded in 2022.
• The largest YoY upside for Cash from Investing Activities was 7207.71% in 2024 against a maximum downside of 14140.45% in 2024.
• Over 5 years, Cash from Investing Activities stood at $20.3 million in 2022, then plunged by 91.12% to $1.8 million in 2023, then surged by 7207.71% to $131.8 million in 2024, then surged by 195.55% to $389.4 million in 2025, then sank by 93.71% to $24.5 million in 2026.
• The last three Cash from Investing Activities figures came in at $24.5 million (Q2 2026), $265.5 million (Q1 2026), and $389.4 million (Q4 2025), per Business Quant data.